Log in to save to my catalogue

Targeting fibrosis: mechanisms and clinical trials

Targeting fibrosis: mechanisms and clinical trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2682577288

Targeting fibrosis: mechanisms and clinical trials

About this item

Full title

Targeting fibrosis: mechanisms and clinical trials

Publisher

London: Nature Publishing Group UK

Journal title

Signal transduction and targeted therapy, 2022-06, Vol.7 (1), Article 206

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Fibrosis is characterized by the excessive extracellular matrix deposition due to dysregulated wound and connective tissue repair response. Multiple organs can develop fibrosis, including the liver, kidney, heart, and lung. Fibrosis such as liver cirrhosis, idiopathic pulmonary fibrosis, and cystic fibrosis caused substantial disease burden. Persis...

Alternative Titles

Full title

Targeting fibrosis: mechanisms and clinical trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2682577288

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2682577288

Other Identifiers

ISSN

2059-3635,2095-9907

E-ISSN

2059-3635

DOI

10.1038/s41392-022-01070-3

How to access this item